TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience
Clinical trial NCT04730323 · COMPLETED
Trial details
- NCT number
- NCT04730323
- Sponsor
- FMH College of Medicine and Dentistry
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2020-06-12
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.